None listed
Conditions
Interventions
None listed
Sponsors
Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. inclusive criteria 1)18~80 years old 2)type 2 diabetes patients with abdominal pain or discomfort, bloating,burnig sense,irritable bowel symptom 3)HbA1c <10% within 3 months during study period 4)no dose changes of drugs that could affect gastrointestinal symptoms within 3 months during study period - PPI, H2 blocker, - prokinetic agents such as Domperidone, Gasmotin, Metoclopromide
Exclusion criteria
Exclusion criteria: Exclusive criteria 1) Impossible communication 2) Patients with psychotic disorders without cooperation 3) Patients with severe heart disease 4) Patients with severe renal disease 5) Patients with severe liver disease 6) Patients with severe lung disease 7) Diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome history 8) Patients with diabetic fool who need treatment immediately 9) Malignancy 10) Pregnancy or lactation 11) Hyperresponsive to clinical drugs 12) Patients who participated in other studies within 30 days before registration 13) Alcohol or drug abuse 14) Patients without agreement to this test plan 15) Hard to undergo this trial Judgmented by doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change of gastrointestinal symptomatic Questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| side effect | — |
Countries
Korea, Republic of
Contacts
Public ContactSang Rhee
Kyung Hee University Hospital
Outcome results
None listed